Company Filing History:
Years Active: 1977
Title: Paul Gold: Innovator in Radionuclide Diagnostic Agents
Introduction
Paul Gold is a notable inventor based in Hollis, NH (US), recognized for his contributions to the field of medical diagnostics. He holds a patent that focuses on radionuclide diagnostic agents, which are essential in the study and diagnosis of kidney morphology and function.
Latest Patents
Gold's patent involves the use of technetium-99m, a reducing agent, and specific polyhydroxycarboxylic acids and their derivatives. These components, including glucoheptonic acid, lactobionic acid, galacturonic acid, and glucuronic acid, along with their salts, are highly useful in diagnosing ischemic, infarcted, or diseased tissue.
Career Highlights
Paul Gold has made significant strides in the medical field through his work at New England Nuclear Corporation. His innovative approach to diagnostic agents has paved the way for advancements in medical imaging and patient care.
Collaborations
Gold has collaborated with esteemed colleagues such as Norman Adler and Leopoldo Lazaro Camin, contributing to the development of effective diagnostic solutions.
Conclusion
Paul Gold's work in radionuclide diagnostic agents exemplifies the impact of innovation in medical diagnostics. His contributions continue to enhance the understanding and treatment of kidney-related conditions.